We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current VIR market cap is 839.32M. The company's latest EPS is USD -3.8059 and P/E is -1.61.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16.79M | 56.38M | 3.35M | 2.38M | 12.37M |
| Operating Income | -131.32M | -80.08M | -132.13M | -257.53M | -117.15M |
| Net Income | -115.97M | -65.28M | -138.38M | -213.72M | -104.59M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 76.37M | 1.1B | 1.62B | 86.18M | 74.21M |
| Operating Income | -296.98M | 420.75M | 833.07M | -676.61M | -587.17M |
| Net Income | -298.67M | 528.58M | 515.84M | -615.06M | -521.96M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.92B | 1.79B | 1.67B | 1.5B | 1.4B |
| Total Liabilities | 328.82M | 246.61M | 235.89M | 257.63M | 248.43M |
| Total Equity | 1.59B | 1.55B | 1.43B | 1.24B | 1.15B |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 918.76M | 1.95B | 2.8B | 1.92B | 1.4B |
| Total Liabilities | 201.91M | 522.42M | 724.13M | 328.82M | 248.43M |
| Total Equity | 716.85M | 1.43B | 2.08B | 1.59B | 1.15B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -778.79M | -109.39M | -187.24M | -358.72M | -446.35M |
| Investing | 164.63M | 28.42M | 240.03M | 358.63M | 499.37M |
| Financing | 7.48M | 152k | 3.09M | 3.13M | 4.39M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -190.94M | -47.59M | 1.66B | -778.79M | -446.35M |
| Investing | -9.86M | -140.81M | -1.19B | 164.63M | 499.37M |
| Financing | 529.47M | 100.33M | 34.76M | 7.48M | 4.39M |
| Market Cap | 839.32M |
| Price to Earnings Ratio | -1.61 |
| Price to Sales Ratio | 11.31 |
| Price to Cash Ratio | 3.76 |
| Price to Book Ratio | 0.73 |
| Dividend Yield | - |
| Shares Outstanding | 137.14M |
| Average Volume (1 week) | 1.04M |
| Average Volume (1 Month) | 1.23M |
| 52 Week Change | -23.50% |
| 52 Week High | 14.43 |
| 52 Week Low | 4.95 |
| Spread (Intraday) | 0.95 (14.62%) |
| Company Name | Vir Biotechnology Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.vir.bio |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
